Clinical Trial: Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients

U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07056439) titled 'Phase I/II Clinical Study of HRS-1738 for the Diagnosis of Prostate Cancer Patients' on June 30.

Brief Summary: This study aims to evaluate the safety and pharmacokinetics of HRS-1738 injection in adult patients with prostate cancer.

Study Start Date: July, 2025

Study Type: INTERVENTIONAL

Condition: PET Imaging in Patients With Prostate Cancer

Intervention: DRUG: HRS-1738 Injection

HRS-1738 injection.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Jiangsu HengRui Medicine Co., Ltd.

Published by HT Digital Content Services with permission from Health Daily Digest....